No idea what is going on behind the scenes (licensing, partnership talks, deals,...), but if it is status quo, I would try to up the image and structure of the company. How difficult can it be to add on some credible board members if the company is sitting on this wonder drug? If they are going to be doing clinical trials, how about a CMO. As a shareholder, I would be interested in finding out what we are paying LW and what exactly are they doing to earn their fee.
News 
Market Data 
Discover 
